TCRLAS: Nine-Level milestone
What has been demonstrated? Assign the highest evidenced milestone while keeping earlier foundations credible.
TCRLAS v2.0 · WORKING METHODOLOGY
Readiness is more than a score.
Independently evidenced maturity, commercial viability, healthcare evidence and human decisions—kept separate.
TCRLAS (Technology Commercialization Readiness Level Assessment System) has been used to help researchers, engineers, and entrepreneurs assess research commercialization. Its use extends across industry. The v2.0 framework supports evidence-based discussion, not automatic investment approval.
CVA: Commercial viability
M/C/E/X/R examine future market opportunity, advantage, economics, execution and risk manageability.
HSE: Healthcare evidence
H1–H5 assess healthcare products and services in their specific category, intended use, claims and jurisdiction.
CDA and launch review
A named human documents the next commercialization action and separately reviews any proposed launch.
No numerical shortcut to authorization.
NE means not evaluated. Zero is an evaluated adverse score. N/A is documented non-applicability, not zero or missing evidence. Neither the lowest dimension nor an average determines a v2 TCRLAS level or approves investment, clinical use or launch.